Data Insights

HF-158K1 by HighField Biopharmaceuticals for Uterine Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Uterine Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Uterine Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Gastric Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Gastric Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Bladder Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Bladder Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Bladder Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Colon Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Colon Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Colon Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Pancreatic Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Pancreatic Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Prostate Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Prostate Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Cervical Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Cervical Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Cervical Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Lung Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Lung Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Lung Cancer

Data Insights

HF-158K1 by HighField Biopharmaceuticals for Ovarian Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - HF-158K1 in Ovarian Cancer